[HTML][HTML] Supplementation of magnolol attenuates skeletal muscle atrophy in bladder cancer-bearing mice undergoing chemotherapy via suppression of FoxO3 …
MC Chen, YL Chen, CF Lee, CH Hung, TC Chou - PloS one, 2015 - journals.plos.org
Skeletal muscle atrophy, the most prominent phenotypic feature of cancer cachexia, is often
observed in cancer patients undergoing chemotherapy. Magnolol (M) extracted from …
observed in cancer patients undergoing chemotherapy. Magnolol (M) extracted from …
[引用][C] Supplementation of Magnolol Attenuates Skeletal Muscle Atrophy in Bladder Cancer-Bearing Mice Undergoing Chemotherapy via Suppression of FoxO3 …
MC Chen, YL Chen, CF Lee, CH Hung… - PLoS ONE, 2015 - ui.adsabs.harvard.edu
Supplementation of Magnolol Attenuates Skeletal Muscle Atrophy in Bladder Cancer-Bearing
Mice Undergoing Chemotherapy via Suppression of FoxO3 Activation and Induction of IGF-1 …
Mice Undergoing Chemotherapy via Suppression of FoxO3 Activation and Induction of IGF-1 …
Supplementation of Magnolol Attenuates Skeletal Muscle Atrophy in Bladder Cancer-Bearing Mice Undergoing Chemotherapy via Suppression of FoxO3 Activation …
MC Chen, YL Chen, CF Lee, CH Hung… - PLoS ONE, 2015 - search.ebscohost.com
Skeletal muscle atrophy, the most prominent phenotypic feature of cancer cachexia, is often
observed in cancer patients undergoing chemotherapy. Magnolol (M) extracted from …
observed in cancer patients undergoing chemotherapy. Magnolol (M) extracted from …
Supplementation of magnolol attenuates skeletal muscle atrophy in bladder cancer-bearing mice undergoing chemotherapy via suppression of FoxO3 activation and …
MC Chen, YL Chen, CF Lee, CH Hung, TC Chou - PLoS ONE, 2015 - go.gale.com
Skeletal muscle atrophy, the most prominent phenotypic feature of cancer cachexia, is often
observed in cancer patients undergoing chemotherapy. Magnolol (M) extracted from …
observed in cancer patients undergoing chemotherapy. Magnolol (M) extracted from …
[PDF][PDF] Supplementation of Magnolol Attenuates Skeletal Muscle Atrophy in Bladder Cancer-Bearing Mice Undergoing Chemotherapy via Suppression of FoxO3 …
MC Chen, YL Chen, CF Lee, CH Hung, TC Chou - PLoS ONE, 2015 - Citeseer
Skeletal muscle atrophy, the most prominent phenotypic feature of cancer cachexia, is often
observed in cancer patients undergoing chemotherapy. Magnolol (M) extracted from …
observed in cancer patients undergoing chemotherapy. Magnolol (M) extracted from …
[引用][C] Supplementation of Magnolol Attenuates Skeletal Muscle Atrophy in Bladder Cancer-Bearing Mice Undergoing Chemotherapy via Suppression of FoxO3 …
MC Chen, YL Chen, CF Lee, CH Hung, TC Chou - PLOS ONE, 2015 - cir.nii.ac.jp
Supplementation of Magnolol Attenuates Skeletal Muscle Atrophy in Bladder Cancer-Bearing
Mice Undergoing Chemotherapy via Suppression of FoxO3 Activation and Induction of IGF-1 …
Mice Undergoing Chemotherapy via Suppression of FoxO3 Activation and Induction of IGF-1 …
[PDF][PDF] Supplementation of Magnolol Attenuates Skeletal Muscle Atrophy in Bladder Cancer-Bearing Mice Undergoing Chemotherapy via Suppression of FoxO3 …
MC Chen, YL Chen, CF Lee, CH Hung, TC Chou - PLoS ONE, 2015 - scienceopen.com
Skeletal muscle atrophy, the most prominent phenotypic feature of cancer cachexia, is often
observed in cancer patients undergoing chemotherapy. Magnolol (M) extracted from …
observed in cancer patients undergoing chemotherapy. Magnolol (M) extracted from …
Supplementation of Magnolol Attenuates Skeletal Muscle Atrophy in Bladder Cancer-Bearing Mice Undergoing Chemotherapy via Suppression of FoxO3 Activation …
MC Chen, YL Chen, CF Lee, CH Hung, TC Chou - Plos one, 2015 - europepmc.org
Skeletal muscle atrophy, the most prominent phenotypic feature of cancer cachexia, is often
observed in cancer patients undergoing chemotherapy. Magnolol (M) extracted from …
observed in cancer patients undergoing chemotherapy. Magnolol (M) extracted from …
[PDF][PDF] Supplementation of Magnolol Attenuates Skeletal Muscle Atrophy in Bladder Cancer-Bearing Mice Undergoing Chemotherapy via Suppression of FoxO3 …
MC Chen, YL Chen, CF Lee, CH Hung, TC Chou - PLoS ONE, 2015 - researchgate.net
Skeletal muscle atrophy, the most prominent phenotypic feature of cancer cachexia, is often
observed in cancer patients undergoing chemotherapy. Magnolol (M) extracted from …
observed in cancer patients undergoing chemotherapy. Magnolol (M) extracted from …
[PDF][PDF] Supplementation of Magnolol Attenuates Skeletal Muscle Atrophy in Bladder Cancer-Bearing Mice Undergoing Chemotherapy via Suppression of FoxO3 …
MC Chen, YL Chen, CF Lee, CH Hung… - PLoS ONE, 2015 - pdfs.semanticscholar.org
Skeletal muscle atrophy, the most prominent phenotypic feature of cancer cachexia, is often
observed in cancer patients undergoing chemotherapy. Magnolol (M) extracted from …
observed in cancer patients undergoing chemotherapy. Magnolol (M) extracted from …